The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Yeleswaram Krishnaswamy since 2026.
This trader's CIK number is 2022156.
At the time of last reporting, Yeleswaram Krishnaswamy was the Chief Development Officer of Rapport Therapeutics, Inc.. (stock ticker symbol RAPP).
Also see all insider trading activities at Rapport Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RAPP | 0 | $0 | 5,680 | $170,684 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-31 | RAPP | Sale | 2,840 | 30.05 | 85,342 |
| 2025-12-31 | RAPP | Sale | 2,840 | 30.05 | 85,342 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yeleswaram Krishnaswamy (Chief Development Officer of Rapport Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.